N-[4-(morpholin-4-yl)phenyl]quinoline-2-carboxamide
|
W417773-10mg
|
≥98% |
190437-83-3 |
10mg
|
¥ 1501.9
|
现货 |
阿拉丁 |
N-[4-(morpholin-4-yl)phenyl]quinoline-2-carboxamide
|
W417773-100mg
|
≥98% |
190437-83-3 |
100mg
|
¥ 7647.9
|
现货 |
阿拉丁 |
1-(4-硝基苄基)-1H-咪唑
|
N182391-25g
|
≥97% |
18994-90-6 |
25g
|
¥ 1960.9
|
现货 |
阿拉丁 |
3-酮-二氢神经鞘胺醇
|
K275506-5mg
|
Moligand™, ≥98% |
18944-28-0 |
5mg
|
¥ 2471.9
|
现货 |
阿拉丁 |
AG-1557
|
A412206-50mg
|
≥98% |
189290-58-2 |
50mg
|
¥ 2038.9
|
现货 |
阿拉丁 |
AG-1557
|
A412206-10mg
|
≥98% |
189290-58-2 |
10mg
|
¥ 620.9
|
现货 |
阿拉丁 |
AG-1557
|
A412206-100mg
|
≥98% |
189290-58-2 |
100mg
|
¥ 3243.9
|
现货 |
阿拉丁 |
3-氨基-2-哌啶酮
|
A121541-25g
|
≥98% |
1892-22-4 |
25g
|
¥ 2581.9
|
期货,请咨询 |
阿拉丁 |
3-氨基-2-哌啶酮
|
A121541-250mg
|
≥98% |
1892-22-4 |
250mg
|
¥ 105.9
|
现货 |
阿拉丁 |
ERK5-IN-2
|
E413634-50mg
|
≥98% |
1888305-96-1 |
50mg
|
¥ 621.9
|
现货 |
阿拉丁 |
ERK5-IN-2
|
E413634-10mg
|
≥98% |
1888305-96-1 |
10mg
|
¥ 166.9
|
现货 |
阿拉丁 |
ERK5-IN-2
|
E413634-100mg
|
≥98% |
1888305-96-1 |
100mg
|
¥ 1055.9
|
期货,请咨询 |
阿拉丁 |
奥塔西德尼(FT-2102)
|
O414289-50mg
|
Moligand™, ≥98% |
1887014-12-1 |
50mg
|
¥ 9499.9
|
现货 |
阿拉丁 |
奥塔西德尼(FT-2102)
|
O414289-10mg
|
Moligand™, ≥98% |
1887014-12-1 |
10mg
|
¥ 2488.9
|
现货 |
阿拉丁 |
奥塔西德尼(FT-2102)
|
O414289-100mg
|
Moligand™, ≥98% |
1887014-12-1 |
100mg
|
¥ 13498.9
|
现货 |
阿拉丁 |
dBET57
|
D412199-50mg
|
≥98% |
1883863-52-2 |
50mg
|
¥ 5668.9
|
现货 |
阿拉丁 |
dBET57
|
D412199-10mg
|
≥98% |
1883863-52-2 |
10mg
|
¥ 1921.9
|
现货 |
阿拉丁 |
dBET57
|
D412199-100mg
|
≥98% |
1883863-52-2 |
100mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
糠基异丙基硫醚
|
F133262-100g
|
≥98%(GC) |
1883-78-9 |
100g
|
¥ 1432.9
|
现货 |
阿拉丁 |
ML327
|
M412178-50mg
|
≥98% |
1883510-31-3 |
50mg
|
¥ 7199.9
|
现货 |
阿拉丁 |
ML327
|
M412178-1mg
|
≥98% |
1883510-31-3 |
1mg
|
¥ 368.9
|
现货 |
阿拉丁 |
MBP146-78
|
M412351-50mg
|
≥99% |
188343-77-3 |
50mg
|
¥ 3924.9
|
现货 |
阿拉丁 |
MBP146-78
|
M412351-10mg
|
≥99% |
188343-77-3 |
10mg
|
¥ 1000.9
|
现货 |
阿拉丁 |
MBP146-78
|
M412351-100mg
|
≥99% |
188343-77-3 |
100mg
|
¥ 6024.9
|
现货 |
阿拉丁 |